NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...
NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...
Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...
Anbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public offering. Read more here.
Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...
Stem-cell research is on the cusp of a breakthrough that could come as soon as 2025, and two biotech companies with promising therapies stand to gain, according to a new report from Maxim Group on ...
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United ...
An international research team has made a notable discovery of fossil embryos belonging to Ecdysozoa, a diverse group of animals including roundworms, velvet worms, insects, and crabs. These ...
In the continual arms race between parasites and their hosts, innovation was thought to be the key to a successful attack or defense that one-ups the competition. But sometimes, as in the ...
These efforts place India at the forefront of the global bioplastics movement, showing the world how biotechnology can contribute to a cleaner, more sustainable future,” Singh said, in October.
GangaGen Biotechnologies receives CARB-X funding to develop Klebicins, a novel protein antibiotic targeting multidrug-resistant Klebsiella pneumoniae lung infections. This addresses a critical ...